HN2011003102A - Piperidinas sustituidas - Google Patents

Piperidinas sustituidas

Info

Publication number
HN2011003102A
HN2011003102A HN2011003102A HN2011003102A HN2011003102A HN 2011003102 A HN2011003102 A HN 2011003102A HN 2011003102 A HN2011003102 A HN 2011003102A HN 2011003102 A HN2011003102 A HN 2011003102A HN 2011003102 A HN2011003102 A HN 2011003102A
Authority
HN
Honduras
Prior art keywords
piperidins
substituted
diseases
treatment
same
Prior art date
Application number
HN2011003102A
Other languages
English (en)
Inventor
Heimbach Dirk
Rohrig Susanne
Cancho Grande Yolanda
Bender Eckhard
Zimmermann Katja
Buchmuller Anja
Gerdes Christoph
Gnoth Mark Jean
Gericke Kersten Matthias
Jeske Mario
Original Assignee
Bayer Ip Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip Gmbh filed Critical Bayer Ip Gmbh
Publication of HN2011003102A publication Critical patent/HN2011003102A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A NUEVAS PIPERIDINAS SUSTITUIDAS, A PROCEDIMIENTOS PARA SU PREPARACION, AL USO DE LAS MISMAS PARA EL TRATAMIENTO Y/O PROFILAXIS DE ENFERMEDADES Y AL USO DE LAS MISMAS PARA LA PRODUCCION DE MEDICAMENTOS PARA EL TRATAMIENTO Y/O PROFILAXIS DE ENFERMEDADES ESPECIALMENTE DE ENFERMEDADES CARDIOVASCULARES Y ENFERMEDADES TUMORALES.
HN2011003102A 2009-05-27 2011-11-24 Piperidinas sustituidas HN2011003102A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102009022894A DE102009022894A1 (de) 2009-05-27 2009-05-27 Substituierte Piperidine

Publications (1)

Publication Number Publication Date
HN2011003102A true HN2011003102A (es) 2015-02-23

Family

ID=42537882

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2011003102A HN2011003102A (es) 2009-05-27 2011-11-24 Piperidinas sustituidas

Country Status (29)

Country Link
US (3) US8440657B2 (es)
EP (1) EP2435431A1 (es)
JP (1) JP5728687B2 (es)
KR (1) KR20120024652A (es)
CN (1) CN102482270B (es)
AR (1) AR076709A1 (es)
AU (1) AU2010252339B2 (es)
BR (1) BRPI1012775A2 (es)
CA (1) CA2763386A1 (es)
CO (1) CO6470822A2 (es)
CR (1) CR20110627A (es)
CU (1) CU24011B1 (es)
DE (1) DE102009022894A1 (es)
EA (1) EA021944B1 (es)
HK (1) HK1171450A1 (es)
HN (1) HN2011003102A (es)
IL (1) IL215903A0 (es)
MA (1) MA33291B1 (es)
MX (1) MX2011012507A (es)
MY (1) MY166555A (es)
NZ (1) NZ596621A (es)
PE (1) PE20120402A1 (es)
SG (1) SG175759A1 (es)
TN (1) TN2011000596A1 (es)
TW (1) TWI464166B (es)
UA (1) UA107576C2 (es)
UY (1) UY32652A (es)
WO (1) WO2010136138A1 (es)
ZA (1) ZA201108609B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009014484A1 (de) 2009-03-23 2010-09-30 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022896A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022894A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
SI2763979T1 (sl) 2011-10-07 2019-04-30 Takeda Pharmaceutical Company Limited 1-arilkarbonil-4-oksi-piperidinske spojine, uporabne za zdravljenje nevrodegenerativnih bolezni
JP5900182B2 (ja) * 2012-06-21 2016-04-06 セントラル硝子株式会社 α，α−ジフルオロ芳香族化合物の製造方法
JP6197348B2 (ja) * 2013-04-25 2017-09-20 セントラル硝子株式会社 α，α−ジフルオロ芳香族化合物の保存安定性の向上方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767144A (en) 1994-08-19 1998-06-16 Abbott Laboratories Endothelin antagonists
AU2722297A (en) 1996-04-03 1997-10-22 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
US6403612B2 (en) 2000-01-31 2002-06-11 Merck & Co., Inc. Thrombin receptor antagonists
ATE345799T1 (de) 2001-10-15 2006-12-15 Janssen Pharmaceutica Nv Substituierte 4-phenyl-4-(1h-imidazol-2-yl)- piperidinderivate zur verringerung von ischämischer schädigung
DE10238113A1 (de) * 2001-12-11 2003-06-18 Bayer Ag Substituierte 2-Thio-3,5-dicyano-4-phenyl-6-aminopyridine und ihre Verwendung
EA200700117A1 (ru) * 2004-06-24 2007-06-29 Инсайт Корпорейшн N-замещенные пиперидины и их применение в качестве фармацевтических препаратов
WO2006002349A1 (en) 2004-06-24 2006-01-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
JP2008504279A (ja) 2004-06-24 2008-02-14 インサイト・コーポレイション アミド化合物およびその医薬としての使用
AU2005273986A1 (en) 2004-08-10 2006-02-23 Incyte Corporation Amido compounds and their use as pharmaceuticals
DE102004042607A1 (de) * 2004-09-03 2006-03-09 Bayer Healthcare Ag Substituierte Phenylaminothiazole und ihre Verwendung
DE102004045796A1 (de) 2004-09-22 2006-03-23 Merck Patent Gmbh Arzneimittel enthaltend Carbonylverbindungen sowie deren Verwendung
EP1705960A1 (en) 2005-03-21 2006-09-27 IEE INTERNATIONAL ELECTRONICS & ENGINEERING S.A. Electroluminescent lamp
WO2007038138A2 (en) 2005-09-21 2007-04-05 Incyte Corporation Amido compounds and their use as pharmaceuticals
EP1979318A1 (en) 2006-01-31 2008-10-15 Incyte Corporation Amido compounds and their use as pharmaceuticals
WO2007101270A1 (en) 2006-03-02 2007-09-07 Incyte Corporation MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
WO2007130898A1 (en) 2006-05-01 2007-11-15 Incyte Corporation TETRASUBSTITUTED UREAS AS MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1
CA2706991A1 (en) * 2007-11-30 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Heteroaryl-substituted piperidines
DE102009014484A1 (de) 2009-03-23 2010-09-30 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022896A1 (de) * 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022897A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022894A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022892A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine
DE102009022895A1 (de) 2009-05-27 2010-12-02 Bayer Schering Pharma Aktiengesellschaft Substituierte Piperidine

Also Published As

Publication number Publication date
US8440657B2 (en) 2013-05-14
MX2011012507A (es) 2011-12-14
TN2011000596A1 (en) 2013-05-24
CN102482270B (zh) 2015-02-25
US8202862B2 (en) 2012-06-19
DE102009022894A1 (de) 2010-12-02
EP2435431A1 (de) 2012-04-04
KR20120024652A (ko) 2012-03-14
SG175759A1 (en) 2011-12-29
CU20110214A7 (es) 2012-03-15
JP2012528089A (ja) 2012-11-12
AU2010252339B2 (en) 2014-10-23
TWI464166B (zh) 2014-12-11
EA201190313A1 (ru) 2012-05-30
EA021944B1 (ru) 2015-10-30
US20120135985A1 (en) 2012-05-31
ZA201108609B (en) 2013-02-27
CR20110627A (es) 2012-03-22
MY166555A (en) 2018-07-16
NZ596621A (en) 2013-12-20
CN102482270A (zh) 2012-05-30
TW201107319A (en) 2011-03-01
MA33291B1 (fr) 2012-05-02
CA2763386A1 (en) 2010-12-02
CO6470822A2 (es) 2012-06-29
AR076709A1 (es) 2011-06-29
WO2010136138A1 (de) 2010-12-02
JP5728687B2 (ja) 2015-06-03
AU2010252339A1 (en) 2011-12-08
CU24011B1 (es) 2014-06-27
HK1171450A1 (en) 2013-03-28
BRPI1012775A2 (pt) 2019-09-24
IL215903A0 (en) 2012-01-31
US20130252948A1 (en) 2013-09-26
PE20120402A1 (es) 2012-04-18
UY32652A (es) 2010-12-31
UA107576C2 (ru) 2015-01-26
US20100305111A1 (en) 2010-12-02

Similar Documents

Publication Publication Date Title
UY31484A1 (es) Piperidinas heteroaril-sustituidas
PA8772101A1 (es) Imidazol-triazolopirimidinas sustituidas
SV2011004019A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
GT200900230A (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y uso
CO7240369A2 (es) Ácido 5-aminotetrahidroquinolin-2-carboxílicos novedosos y su uso
ECSP11011483A (es) Piperidinas sustituidas
UY30663A1 (es) Dihidropirazolonas sustituidas y su uso
WO2013151666A3 (en) Modified polynucleotides for the production of biologics and proteins associated with human disease
WO2013151665A3 (en) Modified polynucleotides for the production of proteins associated with human disease
HN2010002518A (es) Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
SV2010003581A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
CO6300844A2 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
DK3045456T3 (da) Bicyklisk substituerede uraciler og anvendelse heraf
HN2011003102A (es) Piperidinas sustituidas
ECSP099807A (es) (oxazolidinon-5-il-metil)-2-tiofen-carboxamidas sustituidas y su uso en el campo de la coagulación sanguínea
PA8806501A1 (es) Triazolotriazinas y triazolopirazinas y su uso
BR112013020359B8 (pt) Colágeno gelificável e meios para a sua provisão
DOP2015000290A (es) Benzoxazoles sustituidos
HN2010001125A (es) 4-(4-ciano-2-tioaril)dihidropirimidinonas y su uso
CU20100183A7 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa